A grand opening ceremony for the HKU Techno-Entrepreneurship Academy (TEA) in Shenzhen Qianhai was held recently. This ...
Odin Medical, an Olympus Corporation company, has received US Food and Drug Administration (FDA) 510(k) clearance f...
US-based HFS Research has released a report in collaboration with Indegene, elaborating how Generative AI (Gen...
Headquartered in the Netherlands, Royal Philips, a global leader in health technology, has released the Asia P...
Docquity, a leading health tech company established in 2015, has announced its expansion into the B2G sector with the la...
An interdisciplinary team from the Li Ka Shing Faculty of Medicine of the University of Hong Kong (HKUMed) has developed...
Taiwan-based startup JelloX Biotech Inc. has entered into a collaboration through a know-how agreement with Ma...
South Korea-based startup AITRICS has announced the signing of a Memorandum of Understanding (MoU) with ezCare...
The healthcare sector, like many others, has not been immune to the technological shift brought about by artificial inte...
Respiratory diseases are major contributors to global mortality and disability. Chronic obstructive pulmonary disease (C...
QingSong Health, a leading health technology platform based in China, has announced a strategic partnership with Globeth...
The Australian government is investing almost $30 million in research into new ways to use artificial intelligence (AI) ...
Indian firm Fischer Medical Ventures with its wholly owned subsidiary –Time Medical International Ventures (India)...
China-based biotech company MGI Tech Co. has partnered with France-based startup SeqOne, a leading provider of AI-powere...
A team led by Dr Billy SO, core member of the Research Institute for Sports Science and Technology (RISports) and A...
The Ministry of SMEs and Startups, in Korea, held director-general-level discussions with the Estonian Ministry of Socia...
Ryght, a leading enterprise generative AI (GenAI) technology company improving clinical research in the US, has announce...
Oncocross, a Seoul-based artificial intelligence (AI) drug discovery and development biotech startup, has signed a joint...